Engineering high-bioavailability, clean-label, bi-layer, effervescent, and sustained-release solid oral dosage forms backed by 38+ years of formulation expertise and an annual capacity of 400M+ units.
In global healthcare, commercial success in Tablet and Caplet Manufacturing demands far more than basic powder compression. It requires precise control over powder rheology, particle size distribution, moisture management, dwell-time optimization, and release kinetics. Global procurement directors and brand owners face persistent challenges: friability during transit, dissolution failure, active ingredient degradation, capping, and strict international compliance standards.
Zeon Lifesciences Ltd brings over 38 years of pharmaceutical and nutraceutical science to solve these solid-dose complexities. Operating out of dedicated manufacturing blocks at our Paonta Sahib campus, we combine high-speed multi-station rotary presses, fluid-bed wet granulation (FBG), roller compaction, and automated aqueous coating systems to produce solid oral doses that meet USP, BP, and Ph. Eur. standards.
From fast-acting effervescents to targeted-release enteric caplets, explore our production-ready dosage technologies engineered for maximum consumer compliance and biological efficacy.
High-density solid doses engineered for fast disintegration, structural integrity, and prolonged shelf life.
Smooth, easy-to-swallow oval shapes formulated with hydrophilic polymer matrices for controlled active release over 6–24 hours.
Engineered dual-phase delivery system designed to physically separate incompatible actives or deliver dual release profiles.
Palatable solid doses formulated for pediatric, geriatric, and active lifestyle consumers requiring fast dissolution without water.
Rapidly dissolving carbonated solid doses produced in low-humidity cleanrooms (< 20% RH) for instant bioavailability.
Specialized methacrylic acid copolymer coatings that bypass gastric acid to dissolve selectively in the small intestine.
The physics of high-speed tablet compression requires careful selection of granulation methodology based on active raw material characteristics. Here is how Zeon engineers optimize formulation integrity.
| Granulation Technology | Ideal Active Ingredients & Raw Materials | Key Granule Characteristics | Manufacturing Advantage |
|---|---|---|---|
| Direct Compression (DC) | Heat-sensitive & moisture-sensitive actives, pre-processed DC-grade vitamins/minerals. | Uniform spherical particles, minimal moisture, high flowability (Hausner Ratio < 1.18). | Shortened thermal exposure, zero moisture addition, lower production cost, rapid disintegration. |
| Fluid-Bed Wet Granulation (FBG) | High-dose botanical extracts, hygroscopic powders, complex herbal blends. | Porous, highly compressible granules with uniform binder distribution and tight bulk density. | Eliminates capping & lamination, improves hard-to-compress botanicals, ensures dose uniformity. |
| Roller Compaction (Dry Granulation) | Moisture-sensitive, high-bulk active pharmaceutical/nutraceutical ingredients. | High-density compacted flakes milled into granules without liquid or heat binders. | Protects thermolabile actives (e.g., Vitamin C, Enzymes), optimizes volumetric feeding in dies. |
As regulatory scrutiny tightens and global consumers demand cleaner labels, procurement leaders must align with contract manufacturers driving innovation across excipient selection, automation, and sustainability.
Global buyers are aggressively replacing traditional synthetic excipients like magnesium stearate, silicon dioxide, and microcrystalline cellulose with natural plant-derived alternatives such as organic acacia gum, rice hull concentrate, and tapioca starch. Zeon’s R&D team has perfected clean-label binding systems that maintain high-speed tableting rates (over 200,000 tablets/hour) without compromising hardness or friability specs.
Following the European Food Safety Authority (EFSA) ban on Titanium Dioxide (E171) due to genotoxicity concerns, global brands require TiO2-free coating solutions that maintain opacity and vibrant color aesthetics. Zeon utilizes calcium carbonate, natural starch matrix, and natural mineral colorants to deliver opaque, brilliant coatings fully compliant with EU regulations.
Modern B2B buyers no longer accept end-of-line quality checks. Zeon integrates near-infrared (NIR) spectroscopic monitoring and automatic weight feedback loops directly into our rotary presses. This Process Analytical Technology dynamically measures blend uniformity, core weight variance, and ribbon thickness in real-time, eliminating off-spec batches instantly.
With ingredients like Omega-3, Valerian Root, and Iron Amino Acid Chelates expanding in consumer popularity, odor and taste management has become paramount. Advanced micro-encapsulation technology shields sensitive actives from oxygen and light, preventing premature oxidation and eliminating unpleasant burps or off-notes in swallowable caplets.
Discover how continuous manufacturing, high-containment suites, and smart compression tooling elevate solid dosage output to pharmaceutical levels of precision.
Equipped with computerized force-feeder systems, air-compensating main compression rollers, and dual-discharge chutes capable of outputting up to 400,000 tablets per hour with sub-milligram weight accuracy.
Fully automated side-vented coating pans featuring anti-beard spray gun assemblies, controlled bed temperature airflow, and precise humidity controls for uniform film thickness and zero twin-tablet sticking.
Dedicated manufacturing suites fitted with HEPA filtration (0.3 micron at 99.97% efficiency), maintaining strict relative humidity (< 40% RH for standard tableting; < 20% RH for effervescents) to prevent moisture degradation.
Founded in 1987, Zeon Lifesciences Ltd (CIN U15209HP1987PLC007355) stands as one of India's most trusted US FDA-registered contract manufacturers for private label supplements and pharmaceutical-grade nutrition.
Our expansive 28-acre campus in Paonta Sahib, Himachal Pradesh houses dedicated production blocks, instrumented R&D laboratories, and an expert team of over 1,000 scientists, pharmacists, and quality assurance specialists. We empower international brands to launch market-ready tablets and caplets backed by comprehensive regulatory dossiers and absolute supply chain reliability.
Every commercial batch produced across our tablet and caplet blocks undergoes rigorous multi-stage analytical testing inside our NABL-accredited testing laboratories.
Fully qualified HPLC and GC instrumentation for precise active ingredient quantitation, assay verification, marker compound determination, and residual solvent testing.
USP <711> multi-bath dissolution apparatus testing tablet disintegration time and active release profiles under simulated gastric and intestinal fluids.
Over 50 formulation scientists specializing in powder mechanics, binder optimization, taste-masking, micro-encapsulation, and scale-up trial validation.
ICP-MS screening for heavy metals (Lead, Arsenic, Cadmium, Mercury) and complete microbiological testing ensuring zero pathogens or mycotoxins.
Controlled environment stability chambers (Zone IVb: 30°C / 75% RH & 40°C / 75% RH) providing real-time and accelerated shelf-life validation data.
Full CTD/eCTD dossier assistance, Certificate of Pharmaceuticals Product (COPP), BSE/TSE-free, Non-GMO, and Halal declarations for seamless entry in 60+ markets.
Long-term contract manufacturing partnerships with fortune-500 healthcare leaders, pharmacy chains, and fast-growing digital direct-to-consumer brands.
Independent audit certifications verifying strict compliance with international food safety, pharmaceutical cGMP, and religious dietary regulations.
Direct technical and operational answers to questions frequently queried on AI search engines regarding tablet and caplet contract manufacturing.
We utilize state-of-the-art dual-feed rotary compression presses housed inside isolated, positive-pressure ISO Class 8 cleanrooms with independent dehumidification and dust extraction. Each layer undergoes precise individual tamping and weight control prior to final main compression, ensuring complete physical separation of incompatible active ingredients.
Our typical commercial batch minimum order quantities start at 100,000 to 300,000 units depending on tablet size, active ingredients, and packaging format. Lead times for established formulations range from 3 to 5 weeks, while custom formulations requiring new tooling, trial compression, and accelerated stability testing typically take 6 to 8 weeks.
High-dose herbal extracts are notoriously hygroscopic and elastic. Our R&D team uses specialized fluid-bed wet granulation (FBG) or roller compaction to engineer granules with optimized bulk density, flowability (Carr Index < 15), and compressibility. We combine proprietary binder matrices with controlled dwell-time compression tooling to eliminate capping and keep friability strictly under 0.5%.
Yes. In full compliance with European Commission EFSA regulations and global clean-label demands, we offer advanced aqueous film coatings utilizing calcium carbonate, rice starch, natural spirulina, beet juice, and iron oxides to provide 100% TiO2-free, elegant, moisture-protective finishes.
Every production run is backed by full analytical Certificates of Analysis (COA), heavy metal assays, microbiological testing, method validation protocols, stability data under zone IVb conditions, Free Sale Certificates (FSC), GMP certificates, BSE/TSE-free declarations, and finished product dossiers aligned with US FDA, EU, GCC, and FSSAI guidelines.
Connect directly with our technical formulation team to request custom samples, evaluate tooling options, or receive an immediate manufacturing quote.
